ISB has a dedicated Foundation Board chaired by Douglas Howe.
ISB’s researchers rely on philanthropy to conduct our groundbreaking science. Thank you!
You have an essential role to play in the future of human health. You open doors to a new approach that proactively focuses on wellness instead of reacting to disease.
By contributing to ISB, you are part of a team that is committed to shifting the health care model from treating sickness to fostering wellness. We accomplish this with our innovative scientific approach and education program. Together, we are tackling some of the biggest challenges facing human health today, including COVID, cancer, Lyme Disease, sepsis, and Alzheimer’s disease.
You are committed to a better future. ISB is here to make that a reality.
ISB, Attention: Development
401 Terry Ave N, Seattle, WA 98109
Gifts of appreciated stock benefit ISB’s research and may be tax-advantaged for you. Check with your financial advisor or CPA to learn more about making such a gift.
Many employers sponsor a matching gift program and will match your charitable contributions.
Planned gifts offer flexible strategies for your estate and charitable planning.
Come learn about our ongoing research projects and get to know our scientists and educators.
Events allow our corporate partners to reach target audiences who are passionate about our research.
ISB and our collaborative network of partners is pioneering a multimodal approach that combines personal data, lifestyle factors, cognitive training and systems medicine, and is rigorously testing these new approaches in clinical trials. This approach is critical to prevent, slow, and even reverse many neurological conditions before they become irreversible.
ISB Education is continually working to identify effective resources to support student learning. In response to the coronavirus outbreak and the closure of K-12 schools across the nation, we recognize that many schools and families are looking for resources to meet the needs of students.
In a one-of-a-kind study, Merck, ISB and Swedish Medical Center, along with several other research collaborators, have partnered to identify targets for medicines and vaccines for COVID-19.